EquitySectoral/ ThematicDirect · Growth
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option
ITI · Scheme 149268
₹19.83▲ 0.39%NAV · 2026-09-18
Excellent FundScore
AUM
₹263 cr
Expense ratio
0.92%
3Y CAGR
20.3%
Risk level
High
Min SIP
₹500
Benchmark
Nifty 500 TRI
Fund manager: Pradeep GokhaleExit load: Exit load of 0.50%, if redeemed within 3 months.
Excellent · 83/100
A standout fund on our data — strong across almost every dimension.
🎯 For aggressive investors with a 7+ year horizon who can tolerate sharp ups and downs.
📈 Why it could do well
- ✓Compounding well recently — 20.2% CAGR over 3 years.
- ✓Very consistent — delivers dependably across market cycles, ideal for SIPs.
- ✓Protects capital well — worst-ever fall was only 18%.
- ✓3Y CAGR: +20.2%
- ✓Positive 3Y windows: 100% of rolling 3Y windows positive
📉 What could drag it down
- •Sectoral/ Thematics are inherently higher-risk — best held 7+ years to ride out swings.
- •Sharpe ratio: 0.67
- •Sortino ratio: 0.96
FundScore breakdown
83/100 · Excellent
Returns
Excellent
Consistency
Excellent
Risk-adjusted
Decent
Downside protection
Excellent
Cost efficiency
Decent
Portfolio quality
Average
Each dial rates the fund 0–100 on one factor, computed from real NAV history. Fuller & greener = stronger.
SIP return calculator
Back-tested on this fund's actual historical NAVs. Past performance ≠ future returns.